Arcturus Therapeutics Holdings, Inc. (ARCT)
7.195
-0.26
(-3.42%)
USD |
NASDAQ |
Dec 09, 16:00
7.195
0.00 (0.00%)
After-Hours: 18:36
Arcturus Therapeutics Holdings Shareholders Equity (Quarterly): 224.56M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | -7.72M |
| Perspective Therapeutics, Inc. | 242.22M |
| Novavax, Inc. | -156.67M |
| Sangamo Therapeutics, Inc. | 6.243M |
| Myomo, Inc. | 14.63M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 282.34M |
| Total Liabilities (Quarterly) | 57.78M |
| Debt to Equity Ratio | 0.1157 |
| Current Ratio | 7.861 |
| Net Debt Paydown Yield | 0.20% |